Cargando…

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

Immunotherapy using immune checkpoint inhibitors (ICIs) induces durable responses in many metastatic cancers. Metastatic uveal melanoma (mUM), typically occurring in the liver, is one of the most refractory tumours to ICIs and has dismal outcomes. Monosomy 3 (M3), polysomy 8q, and BAP1 loss in prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figueiredo, Carlos R, Kalirai, Helen, Sacco, Joseph J, Azevedo, Ricardo A, Duckworth, Andrew, Slupsky, Joseph R, Coulson, Judy M, Coupland, Sarah E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216965/ https://www.ncbi.nlm.nih.gov/pubmed/31960425 http://dx.doi.org/10.1002/path.5384

Ejemplares similares

Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
por: Farquhar, Neil, et al.
Publicado: (2017)

Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
por: Kalirai, H, et al.
Publicado: (2014)

Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections
por: Zhang, Hongrun, et al.
Publicado: (2020)

BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma
por: Zhang, Chao, et al.
Publicado: (2023)

Transcriptome Profiling Reveals New Insights into the Immune Microenvironment and Upregulation of Novel Biomarkers in Metastatic Uveal Melanoma
por: Krishna, Yamini, et al.
Publicado: (2020)

Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma
por: Jama, N., et al.
Publicado: (2018)

Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention
por: Sabat‐Pośpiech, Dorota, et al.
Publicado: (2022)

Vascular Lakes in Uveal Melanoma and Their Association With Outcome
por: Jones, Hayley, et al.
Publicado: (2022)

Investigating the Role of DUSP4 in Uveal Melanoma
por: Aughton, Karen, et al.
Publicado: (2022)

MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators
por: Aughton, Karen, et al.
Publicado: (2020)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma
por: Robinson, Helena, et al.
Publicado: (2023)

Inhibition of ATM Increases the Radiosensitivity of Uveal Melanoma Cells to Photons and Protons
por: Hussain, Rumana N., et al.
Publicado: (2020)

In-depth proteomic profiling of the uveal melanoma secretome
por: Angi, Martina, et al.
Publicado: (2016)

Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture
por: Aughton, Karen, et al.
Publicado: (2020)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
por: Young, Kelly Z., et al.
Publicado: (2020)

Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma
por: Djulbegovic, Mak B., et al.
Publicado: (2022)

Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma
por: Liu-Smith, Feng, et al.
Publicado: (2020)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers
por: Jang, Geeng-Fu, et al.
Publicado: (2021)

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
por: Masoomian, Babak, et al.
Publicado: (2018)

Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
por: Yen, Matthew, et al.
Publicado: (2018)

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Bakhoum, Mathieu F., et al.
Publicado: (2021)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Author Correction: Estimation of the timing of BAP1 mutation in uveal melanoma progression
por: Uner, Ogul E., et al.
Publicado: (2021)

Small High-Risk Uveal Melanomas Have a Lower Mortality Rate
por: Hussain, Rumana N., et al.
Publicado: (2021)

BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas
por: Kaler, Christopher J., et al.
Publicado: (2022)

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
por: Ewens, K. G., et al.
Publicado: (2018)

Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma
por: Cole, Yasemin C., et al.
Publicado: (2022)

Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome
por: Abbassi, Yasaman Arjmand, et al.
Publicado: (2022)

A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
por: Aoude, Lauren G., et al.
Publicado: (2013)

Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks
por: Sun, Muyi, et al.
Publicado: (2019)

BAP31, a promising target for the immunotherapy of malignant melanomas
por: Yu, Shaojuan, et al.
Publicado: (2015)

Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain
por: Tabuenca Del Barrio, Laura, et al.
Publicado: (2021)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
por: Yin, Jie, et al.
Publicado: (2023)

Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
por: Rola, Alda Cunha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36k2ho1su36vgkubteasbge9u9